CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- S-1/A Offering Registration Statement
- 8-K Event Executive or director change
- FWP Offering Free Writing Prospectus
- S-1/A Offering Registration Statement
- 8-K Event Executive or director change
- 4/A Shares withheld for taxes Interim CEO gave up 6,356 shares (to pay taxes)
- 8-K Event Regulation FD disclosure
- 4 Option exercise Director acquired 8,437 shares (option exercise)
- 4 Option exercise Director acquired 5,000 shares (option exercise)
- 4 Option exercise Director acquired 5,157 shares (option exercise)
- 4 Option exercise Director acquired 5,937 shares (option exercise)
- 4 Option exercise Director acquired 4,844 shares (option exercise)
- 4 Option exercise Interim CEO & President acquired 20,000 shares (option exercise)
- 4 Option exercise Director acquired 5,312 shares (option exercise)
- S-1 Offering Registration Statement
- 8-K Event Executive or director change
- 8-K Event Delisting notice
- 8-K Event Executive or director change
- 4/A Option exercise Director acquired 4,844 shares (option exercise)
- 10-Q Report Quarterly Report
Page 7 of 78 · 1,549 filings